ArticleJournal of Alzheimer's disease : JAD2026
Omics-AD-A multimodal biomarker study on cognitive decline and neuropsychiatric symptoms: Design and cohort characteristics.
Miriam Rabl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.